Tumor lysis syndrome with massive hyperphosphatemia and hyperuricemia.
Abhilash KoratalaPublished in: Clinical case reports (2017)
Tumor lysis syndrome (TLS) occurs when tumor cells release their contents into the bloodstream, typically in response to chemotherapy, leading to the characteristic findings of hyperuricemia, hyperkalemia, hyperphosphatemia, hypocalcemia, and acute kidney injury. Twinkle artifacts on renal ultrasound may indicate calcium phosphate deposits in such patients.
Keyphrases
- acute kidney injury
- end stage renal disease
- ejection fraction
- uric acid
- newly diagnosed
- magnetic resonance imaging
- case report
- prognostic factors
- peritoneal dialysis
- cardiac surgery
- squamous cell carcinoma
- magnetic resonance
- metabolic syndrome
- locally advanced
- patient reported outcomes
- klebsiella pneumoniae
- gram negative
- rectal cancer